Journal of Clinical Endocrinology & Metabolism, Vol 63, 481-484, Copyright © 1986 by Endocrine Society

ARTICLES

Effect of obesity on ambient plasma glucose, free fatty acid, insulin, growth hormone, and glucagon concentrations

A Golay, AL Swislocki, YD Chen, JB Jaspan and GM Reaven

Fasting and postprandial plasma concentrations of glucose, FFA, insulin, glucagon, and GH concentrations were determined in 10 nonobese and 10 obese subjects with normal glucose tolerance. Measurements were made at 0800 h (after a 14-h fast) and at hourly intervals from then until 1600 h. During this time period all individuals ate breakfast at 0800 h (20% of total daily calories) and lunch (40% of total daily calories). Although plasma glucose concentrations were similar throughout the 8-h period in the 2 groups, plasma insulin concentrations were significantly (P less than 0.001) higher in the obese individuals. However, despite the presence of hyperinsulinemia, the obese group also had higher (P less than 0.001) plasma FFA concentration throughout the day. On the other hand, both the absolute and the relative declines in plasma FFA concentration after meals were similar in the 2 groups. Since plasma glucagon and GH concentrations were similar in the 2 groups, altered production of these lipolytic hormones was not responsible for the elevated plasma FFA levels in the obese individuals. These data document the presence in obese individuals of a disassociation in their ability to maintain normal plasma glucose as opposed to plasma FFA homeostasis, and indicate that the increase in plasma FFA concentrations in obesity occurs in the presence of hyperinsulinemia and is not related to abnormalities of either glucagon or GH secretion.

This article has been cited by other articles:

				N. J. Webster, G. J. Searle, P. P. L. Lam, Y.-C. Huang, M. J. Riedel, G. Harb, H. Y. Gaisano, A. Holt, and P. E. Light Elevation in Intracellular Long-Chain Acyl-Coenzyme A Esters Lead to Reduced {beta}-Cell Excitability via Activation of Adenosine 5'-Triphosphate-Sensitive Potassium Channels Endocrinology, July 1, 2008; 149(7): 3679 - 3687. [Abstract] [Full Text] [PDF]

				H. Wang, L. A. Reaves, and N. K. Edens Ginseng Extract Inhibits Lipolysis in Rat Adipocytes In Vitro by Activating Phosphodiesterase 4 J. Nutr., February 1, 2006; 136(2): 337 - 342. [Abstract] [Full Text] [PDF]

				M. J. Riedel and P. E. Light Saturated and cis/trans Unsaturated Acyl CoA Esters Differentially Regulate Wild-Type and Polymorphic {beta}-Cell ATP-Sensitive K+ Channels Diabetes, July 1, 2005; 54(7): 2070 - 2079. [Abstract] [Full Text] [PDF]

				R. Belfort, L. Mandarino, S. Kashyap, K. Wirfel, T. Pratipanawatr, R. Berria, R. A. DeFronzo, and K. Cusi Dose-Response Effect of Elevated Plasma Free Fatty Acid on Insulin Signaling Diabetes, June 1, 2005; 54(6): 1640 - 1648. [Abstract] [Full Text] [PDF]

				T. A. Gresl, R. J. Colman, T. C. Havighurst, L. O. Byerley, D. B. Allison, D. A. Schoeller, and J. W. Kemnitz Insulin sensitivity and glucose effectiveness from three minimal models: effects of energy restriction and body fat in adult male rhesus monkeys Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2003; 285(6): R1340 - R1354. [Abstract] [Full Text] [PDF]

				M. J. Riedel, P. Boora, D. Steckley, G. de Vries, and P. E. Light Kir6.2 Polymorphisms Sensitize {beta}-Cell ATP-Sensitive Potassium Channels to Activation by Acyl CoAs: A Possible Cellular Mechanism for Increased Susceptibility to Type 2 Diabetes? Diabetes, October 1, 2003; 52(10): 2630 - 2635. [Abstract] [Full Text] [PDF]

				C. Hadigan, J. Rabe, G. Meininger, N. Aliabadi, J. Breu, and S. Grinspoon Inhibition of lipolysis improves insulin sensitivity in protease inhibitor-treated HIV-infected men with fat redistribution Am. J. Clinical Nutrition, February 1, 2003; 77(2): 490 - 494. [Abstract] [Full Text] [PDF]

				R. L. Dobbins, L. S. Szczepaniak, J. Myhill, Y. Tamura, H. Uchino, A. Giacca, and J. D. McGarry The Composition of Dietary Fat Directly Influences Glucose-Stimulated Insulin Secretion in Rats Diabetes, June 1, 2002; 51(6): 1825 - 1833. [Abstract] [Full Text] [PDF]

				K. Moens, V. Berger, J.-M. Ahn, C. Van Schravendijk, V. J. Hruby, D. Pipeleers, and F. Schuit Assessment of the Role of Interstitial Glucagon in the Acute Glucose Secretory Responsiveness of In Situ Pancreatic {beta}-Cells Diabetes, March 1, 2002; 51(3): 669 - 675. [Abstract] [Full Text] [PDF]

				M. J. Reginato, S. L. Krakow, S. T. Bailey, and M. A. Lazar Prostaglandins Promote and Block Adipogenesis through Opposing Effects on Peroxisome Proliferator-activated Receptor gamma J. Biol. Chem., January 23, 1998; 273(4): 1855 - 1858. [Abstract] [Full Text] [PDF]

				R. Lanzi, M. F. Manzoni, A. C. Andreotti, M. E. Malighetti, E. Bianchi, L. P. Sereni, A. Caumo, L. Luzi, and A. E. Pontiroli Evidence for an Inhibitory Effect of Physiological Levels of Insulin on the Growth Hormone (GH) Response to GH-Releasing Hormone in Healthy Subjects J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2239 - 2243. [Abstract] [Full Text] [PDF]

				B. M. Egan, M. M.I. Hennes, K. T. Stepniakowski, I. M. O'Shaughnessy, A. H. Kissebah, and T. L. Goodfriend Obesity Hypertension Is Related More to Insulin's Fatty Acid Than Glucose Action Hypertension, March 1, 1996; 27(3): 723 - 728. [Abstract] [Full Text]

				R. K. Bansal, J. L. Ecker, R. K. Laros, J.M. Miles, S.W. Coppack, T. A. Buchanan, S. L. Kjos, M. N. Montoro, M. de Veciana, M. A. Morgan, et al. Blood Glucose Monitoring in Gestational Diabetes Mellitus N. Engl. J. Med., February 29, 1996; 334(9): 598 - 599. [Full Text]